These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 32697762)

  • 21. Sarcomatous Meningioma: Diagnostic Pitfalls and the Utility of Molecular Testing.
    Lucas CG; Devine P; Solomon DA; Giannini C; Reifenberger G; Dahiya S; Caccamo D; Perry A
    J Neuropathol Exp Neurol; 2021 Sep; 80(8):764-768. PubMed ID: 34128073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic and epigenetic alterations in meningiomas.
    Galani V; Lampri E; Varouktsi A; Alexiou G; Mitselou A; Kyritsis AP
    Clin Neurol Neurosurg; 2017 Jul; 158():119-125. PubMed ID: 28527972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging role of non-coding RNA in oral cancer.
    Momen-Heravi F; Bala S
    Cell Signal; 2018 Jan; 42():134-143. PubMed ID: 29056500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence of ubiquitous in vivo and in vitro expression of pro-apoptotic Smac/DIABLO protein in meningioma cell lines.
    Pfister C; Ritz R; Endemann E; Schittenhelm J; Bornemann A; Tatagiba MS; Roser F
    Oncol Rep; 2009 May; 21(5):1181-8. PubMed ID: 19360292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Meningioma Patients at High Risk of Tumor Recurrence Using MicroRNA Profiling.
    Slavik H; Balik V; Vrbkova J; Rehulkova A; Vaverka M; Hrabalek L; Ehrmann J; Vidlarova M; Gurska S; Hajduch M; Srovnal J
    Neurosurgery; 2020 Oct; 87(5):1055-1063. PubMed ID: 32125436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics of MicroRNA Expression Depending on the Presence or Absence of Meningioma in Patients with Neurofibromatosis Type 2: A Secondary Analysis.
    Imura T; Mitsuhara T; Horie N
    Neurol Med Chir (Tokyo); 2024 Mar; 64(3):116-122. PubMed ID: 38267057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-497 and 219 in blood aid meningioma classification.
    Abdelrahman A; Negroni C; Sahm F; Adams CL; Urbanic-Purkart T; Khalil M; Vergura R; Morelli C; Hanemann CO
    J Neurooncol; 2022 Oct; 160(1):137-147. PubMed ID: 36076132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secretory miRNAs as novel cancer biomarkers.
    Zhang J; Zhao H; Gao Y; Zhang W
    Biochim Biophys Acta; 2012 Aug; 1826(1):32-43. PubMed ID: 22440944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma.
    Lusis EA; Watson MA; Chicoine MR; Lyman M; Roerig P; Reifenberger G; Gutmann DH; Perry A
    Cancer Res; 2005 Aug; 65(16):7121-6. PubMed ID: 16103061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LINC00702/miR-4652-3p/ZEB1 axis promotes the progression of malignant meningioma through activating Wnt/β-catenin pathway.
    Li T; Ren J; Ma J; Wu J; Zhang R; Yuan H; Han X
    Biomed Pharmacother; 2019 May; 113():108718. PubMed ID: 30849635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The transmembrane chemokines CXCL16 and CX3CL1 and their receptors are expressed in human meningiomas.
    Li G; Hattermann K; Mentlein R; Mehdorn HM; Held-Feindt J
    Oncol Rep; 2013 Feb; 29(2):563-70. PubMed ID: 23229614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implications.
    Xie SS; Jin J; Xu X; Zhuo W; Zhou TH
    World J Gastroenterol; 2016 Jan; 22(3):1213-23. PubMed ID: 26811659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meningioma: an update.
    Lusis E; Gutmann DH
    Curr Opin Neurol; 2004 Dec; 17(6):687-92. PubMed ID: 15542977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic Biomarkers of Meningioma: A Focused Review.
    Pawloski JA; Fadel HA; Huang YW; Lee IY
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular genetics of meningiomas.
    Ragel BT; Jensen RL
    Neurosurg Focus; 2005 Nov; 19(5):E9. PubMed ID: 16398473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.
    Kong X; Qi J; Yan Y; Chen L; Zhao Y; Fang Z; Fan J; Liu M; Liu Y
    J Cell Biochem; 2019 Oct; 120(10):17963-17974. PubMed ID: 31127661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations of INK4a(p16-p14ARF)/INK4b(p15) expression and telomerase activation in meningioma progression.
    Simon M; Park TW; Köster G; Mahlberg R; Hackenbroch M; Boström J; Löning T; Schramm J
    J Neurooncol; 2001 Dec; 55(3):149-58. PubMed ID: 11859969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Dual Role of MicroRNAs in Colorectal Cancer Progression.
    Ding L; Lan Z; Xiong X; Ao H; Feng Y; Gu H; Yu M; Cui Q
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30227605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylation markers of malignant potential in meningiomas.
    Vengoechea J; Sloan AE; Chen Y; Guan X; Ostrom QT; Kerstetter A; Capella D; Cohen ML; Wolinsky Y; Devine K; Selman W; Barnett GH; Warnick RE; McPherson C; Chiocca EA; Elder JB; Barnholtz-Sloan JS
    J Neurosurg; 2013 Oct; 119(4):899-906. PubMed ID: 23930849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Noncoding RNA landscape and their emerging roles as biomarkers and therapeutic targets in meningioma.
    Joshi R; Sharma A; Kulshreshtha R
    Mol Ther Oncol; 2024 Mar; 32(1):200782. PubMed ID: 38596289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.